Exciting news: Merz Therapeutics has partnered with Stada to bring #BetterOutcomesForMorePatients to Bulgaria. We are excited about the new opportunities this will bring to patients and are grateful that STADA Bulgaria will join us in this mission. Together, we can make a meaningful impact on patients' lives!
Info
At Merz Therapeutics, we seek to address the unique needs of people who suffer from movement disorders, neurological conditions, and other health conditions that severely impact patients’ quality of life. With our patient-centric approach, cutting-edge research and development efforts, highly-scientific medical affairs resources and dedicated commercial teams, we continue the advancement of new and individualized treatment standards, including botulinum toxin. Merz Therapeutics is headquartered in Frankfurt am Main, Germany and is represented in more than 90 countries, with a North America affiliate based in Raleigh, North Carolina. Merz Therapeutics GmbH is part of the Merz Group, a privately held, family-owned company that has dedicated more than 110 years to developing innovations that serve unmet patient and customer needs.
- Website
-
https://www.merztherapeutics.com
Externer Link zu Merz Therapeutics
- Branche
- Arzneimittelherstellung
- Größe
- 501–1.000 Beschäftigte
- Hauptsitz
- Frankfurt am Main
- Kunst
- Privatunternehmen
- Spezialgebiete
- Neurotoxins, Neurology, Neurosciences und Therapeutics
Orte
Beschäftigte von Merz Therapeutics
Aktualisierungen
-
We're delighted to announce that Leonard Paolillo joins Merz Therapeutics as the newly appointed President, Region North America. Len will be a key member of the Global Executive Team while heading up the North America Leadership Team. He will be responsible for leading the commercial strategy and execution of the organization’s expanding product portfolio across the U.S. and Canada businesses. Read the press release here: https://lnkd.in/e5WscqzH
-
Exciting news: we are proud to announce the release of our very first Sustainability Report! We are committed to driving positive change not only in our industry but also on our planet. This report marks a significant step in our journey towards environmental responsibility. Read the full report on our website: https://lnkd.in/etCxCAsq
-
Are you passionate about growth, innovation, strategy, and driving business success? Join our team as Head of Competitive & Strategic Insights! At Merz Therapeutics, we're committed to growth: you'll play a critical role in the future success of our organization as we continually work toward #BetterOutcomesForMorePatients. Learn more about this position: https://lnkd.in/dd6kwuK7
-
At Merz Therapeutics, we believe that partnerships are the cornerstone of innovation and growth. Collaborating with like-minded organizations allows us to combine strengths, share resources, and achieve greater success together. Find out how we can make a difference together: https://lnkd.in/egchjjFy
-
If you care about your brain health, click through the post and incorporate these five tips into your daily routine. The brain is our most vital organ, controlling everything from our thoughts and emotions to our movements and senses. Keeping it healthy is critical to your overall well-being and quality of life. #BetterOutcomesForMorePatients #WorldBrainDay #WBD2024 #BrainHealthandPrevention
-
Collaboration and mutual respect are at the heart of our approach, enabling us to tackle complex challenges and develop breakthrough treatments. By fostering a team culture that values the contributions of each member, we continue to advance our mission of improving patients' quality of life. Become a part of our R&D team: https://lnkd.in/eMcuctE6
-
Did you know that more than 15 million people worldwide are living with a #spinalcordinjury (SCI)? Rehabilitation is a challenging journey that requires resilience, dedication, and comprehensive care, but with the right support, individuals can achieve remarkable levels of independence and quality of life.
-
The innovative strength of our R&D team illustrates the power of collaboration and diversity to achieve breakthroughs in patient care. Together, we are committed to pushing the boundaries of medical science to deliver #BetterOutcomesForMorePatients.
-
For investors and media: We are excited to announce that Merz Therapeutics has officially closed on the acquisition of two commercial medicines, INBRIJA® and AMPYRA®, from Acorda Therapeutics. With these products officially a part of our growing portfolio, we will be able to offer additional treatment options for #Parkinsons related symptoms and, for the first time, #MultipleSclerosis (MS) walking difficulties. The addition of these assets underlines Merz Therapeutics’ global Pivot for Growth strategy to evolve both the current portfolio and achieve critical scale and global reach through acquisitions, while delivering on our ongoing commitment of bringing #BetterOutcomesForMorePatients. Merz Therapeutics is poised to continue building on what we have accomplished in the specialty neurology space by strengthening our market position in Parkinson’s disease and entering the MS segment. This deal demonstrates the organization’s interest and ability to acquire assets in neurology-focused specialty care, driven by the needs of people living with movement disorders and neurological conditions. Read more about the acquisition in our press release: https://lnkd.in/g6yQHSNr #HealthcareInnovation #NeurologyCare Important Safety information: https://lnkd.in/gKbduB4q https://lnkd.in/gyZrZZdr European Medicines Agency (EMA): https://lnkd.in/ezxdVzSP https://lnkd.in/e7g2QT2d
Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics - Merz Therapeutics
merztherapeutics.com